Sperm DNA Damage in β-thalassemia Major: Is There a Role for Antioxidants?
NCT03014882 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2017-01-09
Summary
Accumulation of iron in patients with beta thalassemia major causes free radical formation which leads to damage of biological membranes. Sperm DNA damage may result from these generated antioxidants.
We aimed at investigating the current DNA damage in the sperms of adult patients with beta thalassemia major and the effect generated by giving antioxidant treatment for 6 months.
Conditions
- Endocrine Disease
- Fertility Decreased Male
- DNA Damage
Interventions
- DRUG
-
L-Carnitine and N-acetyl cysteine
Sponsors & Collaborators
-
Ain Shams University
lead OTHER
Principal Investigators
-
Heba H Elsedfy, Professor · Ain Shams University
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 16 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-02-28
- Primary Completion
- 2017-12-31
- Completion
- 2017-12-31
Countries
- Egypt
Study Locations
More Related Trials
-
Zinc Supplementation in Patients With β-Thalassemia Major Complicated With Diabetes Mellitus
NCT03851055 ·Status: COMPLETED ·Phase: PHASE3
-
Dermatological Abnormalities in Beta-thalassemia Major
NCT03894605 ·Status: UNKNOWN
-
Effect of Spirulina Compared to Amlodipine on Cardiac Iron Overload in Children With Beta Thalassemia
NCT02671695 ·Status: COMPLETED ·Phase: NA
-
Adherence of Beta Thalssemia Patients to Oral Chelation Therapy
NCT06568926 ·Status: RECRUITING ·Phase: NA
-
Combination Therapy of Hydroxyurea With L-Carnitine and Magnesium Chloride in Thalassemia Intermedia
NCT00809042 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Efficacy and Safety of Continued Iron Chelation Therapy In Poly-transfused Thalassemia Patients With Low Serum Ferritin (< 500 ng/ml)
NCT01996683 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Alpha-tocopherol in Hemolysis and Oxidative Stress Marker on the Red Cell Membrane Beta-thalassemia Major
NCT03948737 ·Status: COMPLETED ·Phase: NA
-
A Study of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis
NCT00171171 ·Status: COMPLETED ·Phase: PHASE3
-
Hydroxyurea to Treat Beta-Thalassemia (Cooley's Anemia)
NCT00001958 ·Status: COMPLETED ·Phase: PHASE2
-
5-Azacytidine and Phenylbutyrate to Treat Severe Thalassemia
NCT00005934 ·Status: COMPLETED ·Phase: PHASE2
-
Choroidal Thickness in Beta-thalassemia Patients
NCT04067258 ·Status: COMPLETED
-
Evaluating the Effect of N-Acetyl Cysteine and Alpha Lipoic Acid in Patients With Beta Thalassemia
NCT07157722 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Study of SDMB (2,2 Dimethylbutyrate, Sodium Salt) in Beta Thalassemia Intermedia in Thailand
NCT01609595 ·Status: COMPLETED ·Phase: PHASE2
-
Reproductive Capacity and Iron Burden in Thalassemia
NCT02308904 ·Status: COMPLETED ·Phase: NA
-
Effect of Antioxidant Cocktail in Beta-thalassemia/Hb E Patients
NCT01597765 ·Status: COMPLETED ·Phase: NA
-
Inhibitory Effect of a Polyphenol Supplement on Dietary Iron Absorption in Adults with Thalassemia
NCT05326503 ·Status: COMPLETED ·Phase: NA
-
Long-term Clinical Study of CN128 in Thalassemia Patients
NCT04614779 ·Status: COMPLETED ·Phase: PHASE2
-
Gonadal Function in Thalassemic Patient
NCT07288762 ·Status: NOT_YET_RECRUITING
-
B-Thalasaemia Trait and Its Possible Cardioprotective Role
NCT02428023 ·Status: UNKNOWN
-
Benefits of Nigella Sativa in Children With Beta Thalassemia Major
NCT02816957 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Assessment of Pain in People With Thalassemia Who Are Treated With Regular Blood Transfusions
NCT00872833 ·Status: COMPLETED
-
An Algorithm to Start Iron Chelation in Minimally Transfused Young Beta-thalassemia Major Patients
NCT02173951 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Effects of Spirulina on Cardiac Functions in Children With Beta Thalassemia Major
NCT02597595 ·Status: COMPLETED ·Phase: NA
-
Assessment of Pain in People With Thalassemia
NCT00872339 ·Status: COMPLETED
-
Study of The Therapeutic Benefits of Al-hijamah in Children With Beta Thalassemia Major
NCT02761395 ·Status: UNKNOWN ·Phase: NA